- Home
- EPAM vs PEN Comparison
EPAM vs PEN Comparison
Compare EPAM & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EPAM | PEN |
|---|---|---|
| Founded | 1993 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 14.0B |
| IPO Year | 2011 | 2015 |
Fundamental Metrics
Financial Performance| Metric | EPAM | PEN |
|---|---|---|
| Price | $140.63 | $340.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 17 |
| Target Price | $201.07 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 1.5M | 731.1K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | ★ 6.72 | 4.52 |
| Revenue | ★ $1,450,448,000.00 | $1,403,665,000.00 |
| Revenue This Year | $8.92 | $13.92 |
| Revenue Next Year | $8.87 | $13.82 |
| P/E Ratio | ★ $20.76 | $75.77 |
| Revenue Growth | ★ 25.02 | 17.50 |
| 52 Week Low | $125.57 | $221.26 |
| 52 Week High | $222.53 | $362.41 |
Technical Indicators
Market Signals| Indicator | EPAM | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 32.71 | 50.60 |
| Support Level | N/A | $337.63 |
| Resistance Level | $165.67 | $362.41 |
| Average True Range (ATR) | 8.58 | 2.26 |
| MACD | -0.75 | -0.78 |
| Stochastic Oscillator | 22.77 | 43.71 |
Price Performance
Historical ComparisonAbout EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services. The company used to host large engineer bases in Ukraine, Belarus, and Russia, but it now delivers from various locations across different continents. EPAM's largest market is North America, which represents approximately 60% of revenue.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.